Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer Edited (no change to conclusions)
Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Targeted Therapy for Advanced Anaplastic Lymphoma Kinase (ALK)‐rearranged Non‐small Cell Lung Cancer Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439008/all/Targeted_therapy_for_advanced_anaplastic_lymphoma_kinase__ALK_���rearranged_non���small_cell_lung_cancer_Edited__no_change_to_conclusions_. Accessed 26 March 2023.
Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439008/all/Targeted_therapy_for_advanced_anaplastic_lymphoma_kinase__ALK_���rearranged_non���small_cell_lung_cancer_Edited__no_change_to_conclusions_. Accessed March 26, 2023.
Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439008/all/Targeted_therapy_for_advanced_anaplastic_lymphoma_kinase__ALK_���rearranged_non���small_cell_lung_cancer_Edited__no_change_to_conclusions_
Targeted Therapy for Advanced Anaplastic Lymphoma Kinase (ALK)‐rearranged Non‐small Cell Lung Cancer Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439008/all/Targeted_therapy_for_advanced_anaplastic_lymphoma_kinase__ALK_���rearranged_non���small_cell_lung_cancer_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer Edited (no change to conclusions)
ID - 439008
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439008/all/Targeted_therapy_for_advanced_anaplastic_lymphoma_kinase__ALK_���rearranged_non���small_cell_lung_cancer_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -